Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy +/- Tocilizumab for Metastatic Breast Cancer
NCT05846789Phase 2Recruiting
- Start
- Jul 2024
- Primary completion
- Dec 2027
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in breast cancer. Started Jul 2024; status: recruiting.
02
Drugs
tocilizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05846789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05846789.